title: Consensus statement on office-based treatment of opioid dependence using buprenorphine.
authors.affiliation: Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA. david.fiellin@yale.edu
authors.forename: David A
authors.initials: DA
authors.lastname: Fiellin
authors.forename: Herbert
authors.initials: H
authors.lastname: Kleber
authors.forename: Jeanne G
authors.initials: JG
authors.lastname: Trumble-Hejduk
authors.forename: A Thomas
authors.initials: AT
authors.lastname: McLellan
authors.forename: Thomas R
authors.initials: TR
authors.lastname: Kosten
mesh_terms: D000553:Ambulatory Care; D002047:Buprenorphine / Q000627:therapeutic use*; D006556:Heroin Dependence / Q000534:rehabilitation; D006801:Humans; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D009293:Opioid-Related Disorders / Q000534:rehabilitation*; D017410:Practice Guidelines as Topic; D014481:United States
chemical_list: D009292:Narcotic Antagonists; D002047:Buprenorphine